Early Access — free while we kick the tires
EdgarHawk

Bart Filius

Director

Director

Latest: Director buying · June 2026

1 filing analyzed · 1 company · Latest 2026-06-30

Never miss a filing from Bart Filius

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
ProQR Therapeutics N.V. PRQR 1 0 Net buying

Activity

June 2026
medium
Buy
150,000 shares
$231,000
Significance 6/10

Director Bart Filius purchases 150,000 shares of PRQR at $1.54; stock now at $1.86, up 17.7% in 30 days

Bart Filius, a director, purchased 150,000 shares at $1.54 for $231,000.00 on 2026-06-26, establishing an initial position in the company. The current price of $1.86 represents a gain from the transaction price, and the stock has risen 17.7% over the past 30 days and 8.8% over 90 days, reflecting positive recent momentum. However, the stock remains -40.0% below its 52-week high of $3.10, placing this purchase well within a significantly depressed valuation window relative to recent history. This director's initiation of a material holding during a period of downside recovery warrants monitoring of whether this accumulation reflects broader board-level conviction in the company's turnaround trajectory.